News

Clinical Trials Arena27m
Genmab announces Phase Ib/II trial outcomes of epcoritamab combo for DLBCL
Genmab has reported new outcomes from the Phase Ib/II EPCORE NHL-2 trial Arm 10 of T-cell engaging bispecific antibody, ...
Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new ...
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III ...
Translational Data Illustrate A Mechanism Of Greater Potency With Verekitug, A Novel Antibody Antagonist Of The TSLP Receptor
Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for gr ...